Table of Contents:
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Solid Tumor Therapeutics Market: By Therapy Type Market Trends, Size, and Future Outlook
- By Therapy Type Market Size (US$), CAGR (%), and Forecast (2024-2031)
- By Therapy Type Definitions, Technology Landscape
- By Therapy Type Market Drivers
- Product Launches
- Technology Launches
- By Therapy Type Market Restraints
Chapter 4. Solid Tumor Therapeutics Market: By Cancer Type Market Trends, Size, and Future Outlook
- By Cancer Type Market Size (US$), CAGR (%), and Forecast (2024-2031)
- By Cancer Type Definitions, Technology Landscape
- By Cancer Type Market Drivers
- Product Launches
- Technology Launches
- By Cancer Type Market Restraints
Chapter 5. Solid Tumor Therapeutics Market: By Route of Administration Market Trends, Size, and Future Outlook
- By Route of Administration Market Size (US$), CAGR (%), and Forecast (2024-2031)
- By Route of Administration Definitions, Technology Landscape
- By Route of Administration Market Drivers
- Product Launches
- Technology Launches
- By Route of Administration Market Restraints
Chapter 6. Solid Tumor Therapeutics Market: By Distribution Channel Market Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2024-2031)
- By Distribution Channel Definitions, Technology Landscape
- By Distribution Channel Market Drivers
- Product Launches
- Technology Launches
- By Distribution Channel Market Restraints
Chapter 7. Solid Tumor Therapeutics Market: By Mechanism of Action Market Trends, Size, and Future Outlook
- By Mechanism of Action Market Size (US$), CAGR (%), and Forecast (2024-2031)
- By Mechanism of Action Definitions, Technology Landscape
- By Mechanism of Action Market Drivers
- Product Launches
- Technology Launches
- By Mechanism of Action Market Restraints
Chapter 8. Solid Tumor Therapeutics Market: By End-User Market Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2024-2031)
- By End-User Definitions, Technology Landscape
- By End-User Market Drivers
- Product Launches
- Technology Launches
- By End-User Market Restraints
Chapter 9. Solid Tumor Therapeutics Market: Regional Market Trends, Size, and Future Outlook
- North America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Europe
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Asia Pacific
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Latin America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Middle East, and Africa
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2024-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
Chapter 10. Solid Tumor Therapeutics Market: Competitive Landscape
- Roche, Novartis
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Merck & Co.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bristol-Myers Squibb
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- AstraZeneca
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pfizer
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eli Lilly and Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sanofi
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- GlaxoSmithKline
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Amgen
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- AbbVie
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bayer
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Takeda Pharmaceutical
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Astellas Pharma
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eisai
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Daiichi Sankyo
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Ipsen
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Incyte Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Exelixis
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The Solid Tumor Therapeutics Market had an estimated market size of US$ 139.2 billion in 2023.
Increasing cancer prevalence globally, Aging population demographics, Rising healthcare expenditure, Favorable government initiatives, Advancements in targeted therapies and immunotherapies, Improved diagnostic techniques, Increasing cancer awareness and early detection
High treatment costs, Adverse effects of therapies, Stringent regulatory approvals, Lack of patient awareness, Limited access to advanced treatments in developing regions, Complexity of cancer biology and resistance mechanisms, Lack of skilled healthcare professionals in certain regions
The leading component segment in the Solid Tumor Therapeutics Market is the targeted therapy segment, which aims to precisely target specific molecular pathways involved in cancer growth and progression.
The major players operating in the Solid Tumor Therapeutics Market include Roche, Novartis, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Johnson & Johnson, Pfizer, Eli Lilly and Company, Sanofi, GlaxoSmithKline, Amgen, AbbVie, Bayer, Takeda Pharmaceutical, Astellas Pharma, Eisai, Daiichi Sankyo, Ipsen, Incyte Corporation, and Exelixis.
The North America region is expected to lead the Solid Tumor Therapeutics Market during the forecast period, with a market share of 38.7% in 2024.
Increasing cancer prevalence globally, Aging population demographics, Rising healthcare expenditure, Favorable government initiatives, Advancements in targeted therapies and immunotherapies, Improved diagnostic techniques, Increasing cancer awareness and early detection, Emergence of personalized medicine